MAZZUCCHI, SONIA
 Distribuzione geografica
Continente #
NA - Nord America 1.474
EU - Europa 790
AS - Asia 202
AF - Africa 66
OC - Oceania 3
SA - Sud America 1
Totale 2.536
Nazione #
US - Stati Uniti d'America 1.449
IT - Italia 268
SE - Svezia 212
DE - Germania 112
CN - Cina 94
BG - Bulgaria 66
SG - Singapore 61
AT - Austria 43
CI - Costa d'Avorio 41
GB - Regno Unito 31
VN - Vietnam 25
CA - Canada 22
SN - Senegal 17
FI - Finlandia 10
FR - Francia 8
IE - Irlanda 7
IN - India 7
NL - Olanda 7
RU - Federazione Russa 7
TR - Turchia 7
NG - Nigeria 6
BE - Belgio 5
HK - Hong Kong 5
PL - Polonia 5
AU - Australia 3
CZ - Repubblica Ceca 3
ES - Italia 2
IR - Iran 2
MA - Marocco 2
MX - Messico 2
AR - Argentina 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
IM - Isola di Man 1
JP - Giappone 1
NO - Norvegia 1
Totale 2.536
Città #
Woodbridge 196
Fairfield 168
Chandler 139
Ann Arbor 103
Ashburn 86
Houston 84
Seattle 84
Wilmington 69
Sofia 66
New York 64
Cambridge 56
Milan 56
Serra 42
Abidjan 41
Vienna 41
Florence 39
Frankfurt am Main 39
Boardman 35
Princeton 35
Lawrence 30
Medford 29
Beijing 28
Pisa 26
Trieste 23
Bremen 21
Guangzhou 21
Ottawa 19
Des Moines 18
Dakar 17
Ogden 14
Dong Ket 11
Dearborn 10
San Diego 10
Singapore 10
Los Angeles 9
Nanjing 8
Istanbul 6
Lagos 6
London 6
Massa E Cozzile 6
Norwalk 6
Nürnberg 6
Brussels 5
Redwood City 5
Warsaw 5
Falls Church 4
Galway 4
Hong Kong 4
Lancaster 4
Shanghai 4
Vecchiano 4
Vicopisano 4
Brno 3
Indiana 3
Moscow 3
Paris 3
Rho 3
Santa Clara 3
Agadir 2
Amsterdam 2
Barcelona 2
Burlington 2
Calgary 2
Canosa Di Puglia 2
Changsha 2
Cuauhtémoc 2
Harbin 2
Hebei 2
Hefei 2
Kostroma 2
Manchester 2
Massarosa 2
Maynooth 2
Medolago 2
Nanchang 2
Pune 2
Rome 2
Rourkela 2
Shenyang 2
Southwark 2
Tianjin 2
Utrecht 2
Xian 2
Acton 1
Ames 1
Baotou 1
Bergen 1
Boston 1
Boydton 1
Brescia 1
Buenos Aires 1
Böblingen 1
Central 1
Chehalis 1
Chicago 1
Clifton 1
Dallas 1
Douglas 1
Dublin 1
Edinburgh 1
Totale 1.911
Nome #
Chronic Migraine with Medication Overuse and OnabotulinumtoxinA: Two Positive Case Reports of a Modified Injection Protocol 147
Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction 140
Social Cognition and Oxytocin in Huntington’s Disease: New Insights 131
Efficacy of a combined therapeutic approach in the management of Pisa Syndrome 122
The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-na?ve patients with Parkinson's disease. 115
Current treatment and future prospects of dopa-induced dyskinesias. 115
Antipsychotic drugs in Huntington's disease 115
Migraine features in migraineurs with and without anxiety-depression symptoms: A hospital-based study 112
Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease. 103
Brain-Derived Neurotrophic Factor (BDNF) and Serotonin Transporter (SERT) in Platelets of Patients with Mild Huntington’s Disease: Relationships with Social Cognition Symptoms 102
Different Clinical Contexts of Use of Blood Neurofilament Light Chain Protein in the Spectrum of Neurodegenerative Diseases 97
Symptomatic orthostatic tremor associated with Graves' disease. 89
Postural Abnormalities in Parkinson's Disease: An Epidemiological and Clinical Multicenter Study 89
null 86
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up 81
Head tremor as a warning symptom of rapidly progressive syringomyelia: a case report 80
Bipolar Spectrum disorders in Parkinson's disease: a systematic evaluation 77
null 75
Plasma levels of oxidative stress markers, before and after BoNT/A Treatment, in chronic migraine 74
Automated MRI Classification in Progressive Supranuclear Palsy: a Large International Cohort Study 70
Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis 64
Quantitative susceptibility mapping in atypical Parkinsonisms 62
Prevalence and clinical correlates of comorbid anxiety and panic disorders in patients with Parkinson’s disease 48
Does the Degree of Trunk Bending Predict Patient Disability, Motor Impairment, Falls, and Back Pain in Parkinson's Disease? 44
A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study 44
Supersaturation of VEP in Migraine without Aura Patients Treated with Topiramate: An Anatomo-Functional Biomarker of the Disease 43
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region 42
Cgrp inhibitors and oxidative stress biomarkers in resistant migraine: A real‐life study with erenumab, fremanezumab and galcanezumab 40
Neuroimaging in idiopathic adult-onset focal dystonia 39
Nigral involvement and nigrostriatal dysfunction in Huntington's disease: evidences from an MRI and SPECT study. 35
The role of synaptic biomarkers in the spectrum of neurodegenerative diseases 33
Functional gait disorders: Demographic and clinical correlations 31
Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease 16
Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms 13
Perampanel as a novel treatment for subcortical myoclonus in myoclonus-dystonia syndrome 10
Data-driven clustering of combined Functional Motor Disorders based on the Italian registry 10
Totale 2.594
Categoria #
all - tutte 8.640
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.640


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020341 0 0 44 24 30 50 43 40 45 31 20 14
2020/2021273 11 44 7 16 12 10 65 16 21 18 13 40
2021/2022378 9 6 5 23 73 51 13 23 34 18 27 96
2022/2023606 81 88 53 38 52 64 8 31 121 0 59 11
2023/2024407 34 33 41 37 48 87 24 19 5 13 37 29
2024/202553 13 40 0 0 0 0 0 0 0 0 0 0
Totale 2.594